Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 28, 2016; 22(8): 2434-2440
Published online Feb 28, 2016. doi: 10.3748/wjg.v22.i8.2434
Published online Feb 28, 2016. doi: 10.3748/wjg.v22.i8.2434
Table 1 Biomarkers identified as mediators of metastasis in gastric cancer
| Biomarkers | Target gene(s) | Ref. |
| Growth factors | ||
| VEGF | CD34, CD11b, c-kit, and Sca-1 | [14] |
| PDGF-B | [13] | |
| EGF | EGFR | [46] |
| Chemokines | ||
| SDF-1 | CXCR4 | [30] |
| TNF-α | TNFR I/II | [31] |
| TGF-β | TSP1, SMAD4 | [55,56] |
| EVs | ||
| Exosomes | HOXD10 and PTEN | [39] |
| ECM Proteases | ||
| E-cadherin | [45] | |
| Rho GTPases: Rac1, RhoA and RhoC | [49,50] | |
| MMP-2, MMP-7, MMP-9 and MT1-MMP | [20-22] | |
| VLA-4 | VCAM-1 | [18] |
| MicroRNAs | ||
| miR-200b | ZEB1 and ZEB2 | [71] |
| miR-141 | ZEB1 | [72] |
| miR-375 | JAK-2 | [73,74] |
| miR-10b | HOXD10 | [75] |
| miR-21 | RECK, PTEN and PDCD4 | [76-78] |
- Citation: Zhong J, Chen Y, Wang LJ. Emerging molecular basis of hematogenous metastasis in gastric cancer. World J Gastroenterol 2016; 22(8): 2434-2440
- URL: https://www.wjgnet.com/1007-9327/full/v22/i8/2434.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i8.2434
